Related references
Note: Only part of the references are listed.Role of Oxidative Stress in the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Implications for Prevention and Therapy
Johanna C. Arroyave-Ospina et al.
ANTIOXIDANTS (2021)
Hepatic Stellate Cell Activation and Inactivation in NASH-Fibrosis-Roles as Putative Treatment Targets?
Alexandra Zisser et al.
BIOMEDICINES (2021)
Challenges and opportunities in drug development for nonalcoholic steatohepatitis
Matthias Ocker
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Redefining non-alcoholic fatty liver disease: what's in a name?
[Anonymous]
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
From NAFLD to MAFLD: when pathophysiology succeeds
Herbert Tilg et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Pirfenidone Is an Agonistic Ligand for PPARα and Improves NASH by Activation of SIRT1/LKB1/pAMPK
Ana Sandoval-Rodriguez et al.
HEPATOLOGY COMMUNICATIONS (2020)
Insights Into the Characteristics of Sweet Syndrome in Patients With and Without Hematologic Malignancy
Siting Zheng et al.
FRONTIERS IN MEDICINE (2020)
Pirfenidone prevents and reverses hepatic insulin resistance and steatohepatitis by polarizing M2 macrophages
Guanliang Chen et al.
LABORATORY INVESTIGATION (2019)
Fatty Acid Desaturase Involvement in Non-Alcoholic Fatty Liver Disease Rat Models: Oxidative Stress Versus Metalloproteinases
Giuseppina Palladini et al.
NUTRIENTS (2019)
miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease
Jun-Ke Long et al.
MOLECULAR MEDICINE (2019)
Green Tea Prevents NAFLD by Modulation of miR-34a and miR-194 Expression in a High-Fat Diet Mouse Model
L. F. Torres et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
Chris Estes et al.
HEPATOLOGY (2018)
Human hepatic stellate cell isolation and characterization
Linshan Shang et al.
JOURNAL OF GASTROENTEROLOGY (2018)
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Zobair Younossi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Total RNA extraction from tissues for microRNA and target gene expression analysis: not all kits are created equal
Rikki A. M. Brown et al.
BMC BIOTECHNOLOGY (2018)
A circulating microRNA signature as noninvasive diagnostic and prognostic biomarkers for nonalcoholic steatohepatitis
Jie Liu et al.
BMC GENOMICS (2018)
Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease
David Hojland Ipsen et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2018)
Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease
Mario Masarone et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2018)
Changes in the immune system - the key to diagnostics and therapy of patients with non-alcoholic fatty liver disease
Marcin Kosmalski et al.
CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY (2018)
A vicious circle between insulin resistance and inflammation in nonalcoholic fatty liver disease
Zhonge Chen et al.
LIPIDS IN HEALTH AND DISEASE (2017)
Clinical epidemiology and disease burden of nonalcoholic fatty liver disease
Brandon J. Perumpail et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Are miRNA-103, miRNA-107 and miRNA-122 Involved in the Prevention of Liver Steatosis Induced by Resveratrol?
Ana Gracia et al.
NUTRIENTS (2017)
Antifibrotic effect of pirfenidone in a mouse model of human nonalcoholic steatohepatitis
Chikara Komiya et al.
SCIENTIFIC REPORTS (2017)
Pirfenidone attenuates bleomycin-induced pulmonary fibrosis in mice by regulating Nrf2/Bach1 equilibrium
Yuan Liu et al.
BMC PULMONARY MEDICINE (2017)
Systematic integrative analysis of gene expression identifies HNF4A as the central gene in pathogenesis of non-alcoholic steatohepatitis
Cristina Baciu et al.
PLOS ONE (2017)
MicroRNA-21 is a potential link between non-alcoholic fatty liver disease and hepatocellular carcinoma via modulation of the HBP1-p53-Srebp1c pathway
Heng Wu et al.
GUT (2016)
Liver microRNA-21 is overexpressed in non-alcoholic steatohepatitis and contributes to the disease in experimental models by inhibiting PPARα expression
Xavier Loyer et al.
GUT (2016)
Nonalcoholic Fatty Liver Disease in Latinos
Sammy Saab et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Role of MicroRNAs in NAFLD/NASH
Gyongyi Szabo et al.
DIGESTIVE DISEASES AND SCIENCES (2016)
Stress-activated miR-21/miR-21* in hepatocytes promotes lipid and glucose metabolic disorders associated with high-fat diet consumption
Nicolas Calo et al.
GUT (2016)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
Molecular Pathogenesis of NASH
Alessandra Caligiuri et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
PHARMACOKINETICS OF THE ANTIFIBROTIC DRUG PIRFENIDONE IN CHILD PUGH A AND B CIRRHOTIC PATIENTS COMPARED TO HEALTHY AGE-MATCHED CONTROLS
J. L. Poo et al.
JOURNAL OF HEPATOLOGY (2016)
miRNAs in non-alcoholic fatty liver disease
Zhen He et al.
FRONTIERS OF MEDICINE (2016)
Novel hepatic microRNAs upregulated in human nonalcoholic fatty liver disease
Jarkko Soronen et al.
PHYSIOLOGICAL REPORTS (2016)
Role and New Insights of Pirfenidone in Fibrotic Diseases
David Alejandro Lopez-de la Mora et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2015)
miR-21 regulates triglyceride and cholesterol metabolism in non-alcoholic fatty liver disease by targeting HMGCR
Chuanzheng Sun et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2015)
miR-122-A key factor and therapeutic target in liver disease
Simonetta Bandiera et al.
JOURNAL OF HEPATOLOGY (2015)
miRNA-103: Molecular link between insulin resistance and nonalcoholic fatty liver disease
Qian Xu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
A metabolic stress-inducible miR-34a-HNF4α pathway regulates lipid and lipoprotein metabolism
Yang Xu et al.
NATURE COMMUNICATIONS (2015)
Effect of miR-34a in regulating steatosis by targeting PPARα expression in nonalcoholic fatty liver disease
Jiexia Ding et al.
SCIENTIFIC REPORTS (2015)
Nonalcoholic fatty liver disease
Elizabeth M. Brunt et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
MicroRNAs in Nonalcoholic Fatty Liver Disease
Gyoergy Baffy
JOURNAL OF CLINICAL MEDICINE (2015)
Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis
Carlos J. Pirola et al.
GUT (2015)
Transforming Growth Factor Beta Signaling in Hepatocytes Participates in Steatohepatitis Through Regulation of Cell Death and Lipid Metabolism in Mice
Ling Yang et al.
HEPATOLOGY (2014)
MicroRNAs in liver disease
Gyongyi Szabo et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis
Seung-Hoi Koo
CLINICAL AND MOLECULAR HEPATOLOGY (2013)
Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis
Anabela P. Rolo et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Transition from hepatic steatosis to steatohepatitis: Unique microRNA patterns and potential downstream functions and pathways
Xi Jin et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2012)
Lycopene inhibits hepatic steatosis via microRNA-21-induced downregulation of fatty acid-binding protein 7 in mice fed a high-fat diet
Jiyun Ahn et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2012)
The Role of MicroRNAs in Cholesterol Efflux and Hepatic Lipid Metabolism
Kathryn J. Moore et al.
ANNUAL REVIEW OF NUTRITION, VOL 31 (2011)
MicroRNAs 103 and 107 regulate insulin sensitivity
Mirko Trajkovski et al.
NATURE (2011)
Obesity and Nonalcoholic Fatty Liver Disease: Biochemical, Metabolic, and Clinical Implications
Elisa Fabbrini et al.
HEPATOLOGY (2010)
Pirfenidone inhibits carbon tetrachloride- and albumin complex-induced liver fibrosis in rodents by preventing activation of hepatic stellate cells
Xin-Yan Zhao et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2009)
miR-21: a small multi-faceted RNA
Anna M. Krichevsky et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Da Wei Huang et al.
NATURE PROTOCOLS (2009)
Potent antioxidant role of Pirfenidone in experimental cirrhosis
Adriana Salazar-Montes et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Nonalcoholic Steatohepatitis Is Associated with Altered Hepatic MicroRNA Expression
Onpan Cheung et al.
HEPATOLOGY (2008)
Liver X receptor in cooperation with SREBP-1c is a major lipid synthesis regulator in nonalcoholic fatty liver disease
Nobito Higuchi et al.
HEPATOLOGY RESEARCH (2008)
Analyzing real-time PCR data by the comparative C-T method
Thomas D. Schmittgen et al.
NATURE PROTOCOLS (2008)
Hepatic stellate cells: Protean, multifunctional, and enigmatic cells of the liver
Scott L. Friedman
PHYSIOLOGICAL REVIEWS (2008)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
The anti-fibrotic effect of pirfenidone in rat liver fibrosis is mediated by downregulation of procollagen α1(I), TIMP-1 and MMP-2
A Di Sario et al.
DIGESTIVE AND LIVER DISEASE (2004)
Pirfenidone effectively reverses experimental liver fibrosis
L García et al.
JOURNAL OF HEPATOLOGY (2002)
Share Paper
